本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kymera Therapeutics, Inc.

44.91
+0.01000.02%
盘前44.910.00000.00%08:00 EDT
成交量:106.17万
成交额:4,741.21万
市值:31.51亿
市盈率:-14.43
高:45.33
开:45.30
低:43.66
收:44.90
数据加载中...
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/14

重要事件披露

Form 8-K - Current report
2025/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/22

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/20

重要事件披露

Form 8-K - Current report
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities